dextrothyroxine has been researched along with hydroxychloroquine in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 41 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fabbrocini, G; Patrì, A | 1 |
| Şimşek Yavuz, S; Ünal, S | 1 |
| Tapia, L | 1 |
| Anastasiou, IA; Eleftheriadou, I; Tentolouris, A; Tentolouris, N; Tsilingiris, D | 1 |
| Hajlaoui, K; Karray, M; Litaiem, N; Slouma, M; Zeglaoui, F | 1 |
| Alvarez, RA; Auerbach, JS; de Marchena, EJ; Delazerda, D; Ghodsizad, A; Grant, AA; Guerra, G; Hare, J; Khalid, L; Loebe, M; Mirsaeidi, M; Sneij, WC; Vianna, R | 1 |
| Gupta, SP | 1 |
| González-Cuevas, R; Ortega-Peña, M | 1 |
| Goodridge, A; Torres-Atencio, I; Vega, S | 1 |
| Mishra, SK; Tripathi, T | 1 |
| Kumar, D; Trivedi, N; Verma, A | 1 |
| Dadvand, H; Davoodian, P; Fathalipour, M; Ghazizadeh, S; Hassaniazad, M; Hassanipour, S; Hosseini, FS; Kahoori, S; Malektojari, A; Nikoofal-Sahlabadi, S; Nikpoor, AR; Sepandi, M | 1 |
| Wen, S; Xu, X; Yadav, AK; Yu, L | 1 |
| Domb, AJ; Neuberger, A; Petersiel, N; Rakedzon, S; Schwartz, E | 1 |
| Furuya, K; Goudarzi, H; Ohe, M | 1 |
| Araújo, AMM; Araújo, JV; Asato, MS; Buttenbender, SF; Carbonell, RCC; da Fonseca, AJ; Da Rocha, JG; de Andrade, SB; de Lima Moreira, A; de Sousa Resende, J; de Souza, RGS; Galan, LEB; Marques, FSS; Paiva, ADP; Portella, DGS; Santos, NMD; Santos, PL; Silva, GMA; Tizolim, MR | 1 |
| Agarwal, A; Agoritsas, T; Azab, M; Bartoszko, JJ; Brignardello-Petersen, R; Chu, DK; Couban, R; Devji, T; Foroutan, F; Ghadimi, M; Guyatt, GH; Honarmand, K; Ibrahim, S; Izcovich, A; Khamis, A; Kum, E; Lamontagne, F; Loeb, M; Martinez, JPD; McLeod, SL; Motaghi, S; Murthy, S; Mustafa, RA; Qasim, A; Rochwerg, B; Roldan, Y; Siemieniuk, RAC; Soto, GB; Switzer, C; Thabane, L; Vandvik, PO; Vernooij, RWM; Wang, Y; Yao, L; Zeraatkar, D | 1 |
| Avcı, İY; Çetinkaya, RA; Demirtürk, N; Eser, F; Güner, R; Karalezli, A; Kayaaslan, B; Konya, P; Okumuş, N; Orhan, S; Savaşçı, Ü; Şaylan, B; Taşkın, G; Yamanel, L; Yılmaz, G | 1 |
| Chandra, PP; Jain, S; Potschka, H; Tripathi, M; Vohora, D | 1 |
| Arabi, M; Bitar, F; Eid, AH; Fakhri, G; Younis, NK; Zareef, RO | 1 |
| Nogrady, B | 1 |
| Rein, T | 1 |
| Bhattacharrya, D; Chakrbarty, A; Mondal, T; Mukherjee, S; Paul, J; Saha, B; Samajdar, SS; Tripathi, R; Tripathi, SK | 1 |
| Beranger, RW; Ferreira, RM; Lima, RAC; Mansur Filho, J; Sampaio, PPN | 1 |
| Watson, C | 1 |
| Bhardwaj, M; Chiu, MN; Sah, SP | 1 |
| Dauby, N; Hites, M; Taccone, FS | 1 |
| Barnett, ML; Gaye, M; Jena, AB; Mehrotra, A | 1 |
| Boretti, A | 1 |
| Kieliszek, M | 1 |
| Atal, S; Kaore, S | 1 |
| Elliott, JH; Henry, D; Pearson, SA; Schaffer, AL; Zoega, H | 1 |
| Bates, DW; Hua, Y; Jiang, H; Lin, S; Plasek, JM; Yang, J; Zhou, L | 1 |
| Abdallah, MS; Abdel Ghaffar, MM; Elsawah, HK; Elshafie, AH; Goda, FM; Hammad, M; Mosalam, EM; Seif, AS; Sweed, EM | 1 |
| Borges, P; Botton, MR; Freitas, M; Hentschke-Lopes, M; Mancuso, ACB; Matte, U | 1 |
| Gomes, T; Ho, M; Iacono, A; Suda, K; Tadrous, M | 1 |
| Hill, A; Mirchandani, M | 1 |
| Giarolla, J; Parise-Filho, R; Polli, MC; Vassiliades, SV; Vaz, ES | 1 |
| Barbosa, AN; Bernardo, WM; Chebabo, A; Cimerman, S; Croda, J; Cunha, CA; de Luna, D; Falavigna, M; Ferreira, JC; Gomes-da-Silva, MM; Nunes, EP; Parahiba, SM; Pérez, C; Rodriguez-Morales, AJ; Starling, C; Tanni, S; Thormann, M; Zambrano, G | 1 |
| Bijlsma, MJ; de Vos, S; Hak, E; Mol, P; Niesters, HGM; Oude Rengerink, K; Pasmooij, AMG; van Baarle, D; Verweij, S; Vonk, JM; Zhou, G | 1 |
| Druckman, JN; Green, J; Lazer, D; Lunz Trujillo, K; Ognyanova, K; Perlis, RH; Safarpour, A; Santillana, M | 1 |
18 review(s) available for dextrothyroxine and hydroxychloroquine
| Article | Year |
|---|---|
Antiviral treatment of COVID-19
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2; Thiazoles | 2020 |
Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; COVID-19 Vaccines; Gene Expression; Host-Pathogen Interactions; Humans; Hydroxychloroquine; Immunization, Passive; Ivermectin; Models, Molecular; Niclosamide; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protein Interaction Domains and Motifs; Protein Structure, Secondary; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus; Viral Vaccines | 2020 |
Familiar Dermatologic Drugs as Therapies for COVID-19.
Topics: Androgen Antagonists; Antimalarials; Antioxidants; Antiparasitic Agents; Chloroquine; Cinchona; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Ivermectin; Melatonin; SARS-CoV-2; Virus Internalization | 2021 |
One year update on the COVID-19 pandemic: Where are we now?
Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; Chloroquine; Clinical Trials as Topic; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Vaccines; Drug Combinations; Drug Repositioning; Glucocorticoids; Humans; Hydroxychloroquine; Indoles; Ivermectin; Lopinavir; Mutation; Pandemics; Phytotherapy; Plant Extracts; Pyrazines; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tinospora; Viral Zoonoses | 2021 |
Possible treatment and strategies for COVID-19: review and assessment.
Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antiparasitic Agents; Antiviral Agents; Cannabinoids; Chloroquine; Complement Inactivating Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; COVID-19 Vaccines; Dexamethasone; Drug Combinations; Enzyme Inhibitors; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Pyrazines; Ritonavir; SARS-CoV-2; Teicoplanin; Tetracyclines; Thiazoles | 2020 |
Antiviral treatment in COVID-19: which is the most promising?-a narrative review.
Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Chloroquine; COVID-19; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Oseltamivir; Purines; Pyrazines; Pyrazoles; Ribavirin; Ritonavir; Sulfonamides; Thiazoles | 2021 |
From hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2?
Topics: Animals; Antiparasitic Agents; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Hydroxychloroquine; Ivermectin; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2 | 2021 |
Prophylaxis against covid-19: living systematic review and network meta-analysis.
Topics: Anti-Infective Agents; Carrageenan; Chemoprevention; COVID-19; Global Health; Humans; Hydroxychloroquine; Ivermectin; SARS-CoV-2; Treatment Outcome; Uncertainty | 2021 |
Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications.
Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Anticonvulsants; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Cytochrome P-450 CYP3A Inducers; Dexamethasone; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Epilepsy; Glucocorticoids; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Ivermectin; Lopinavir; Pyrazines; Ritonavir; SARS-CoV-2 | 2021 |
COVID-19: potential therapeutics for pediatric patients.
Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Child; COVID-19 Drug Treatment; Dexamethasone; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Oseltamivir; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2021 |
Harnessing autophagy to fight SARS-CoV-2: An update in view of recent drug development efforts.
Topics: Antidepressive Agents; Antiviral Agents; Artesunate; Autophagy; Chloroquine; COVID-19 Drug Treatment; Drug Development; Drug Repositioning; Endoplasmic Reticulum; Endosomes; Humans; Hydroxychloroquine; Imatinib Mesylate; Infliximab; Intracellular Membranes; Ivermectin; Macrolides; Middle East Respiratory Syndrome Coronavirus; Niclosamide; Pandemics; RNA, Viral; SARS-CoV-2; Virus Replication | 2022 |
Safety profile of COVID-19 drugs in a real clinical setting.
Topics: Antiviral Agents; Chloroquine; COVID-19 Drug Treatment; Dexamethasone; Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Reproducibility of Results; Ritonavir; SARS-CoV-2 | 2022 |
Zinc augments the antiviral potential of HCQ/CQ and ivermectin to reduce the risks of more serious outcomes from COVID-19 infection.
Topics: Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Ivermectin; SARS-CoV-2; Treatment Outcome; Zinc | 2022 |
Selenium in the Prevention of SARS-CoV-2 and Other Viruses.
Topics: COVID-19; Humans; Hydroxychloroquine; Ivermectin; SARS-CoV-2; Selenium | 2023 |
Molnupiravir in COVID-19: A Scoping Review.
Topics: Adrenal Cortex Hormones; Animals; Antiviral Agents; COVID-19 Drug Treatment; Cricetinae; Ferrets; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Mice; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2 | 2022 |
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies.
Topics: Antiviral Agents; Azithromycin; Chloroquine; COVID-19; Dexamethasone; Drug Repositioning; Humans; Hydroxychloroquine; Ivermectin; Methylprednisolone; Pandemics; Reproducibility of Results; SARS-CoV-2 | 2023 |
Pan-American Guidelines for the treatment of SARS-CoV-2/COVID-19: a joint evidence-based guideline of the Brazilian Society of Infectious Diseases (SBI) and the Pan-American Association of Infectious Diseases (API).
Topics: Antiviral Agents; Brazil; Communicable Diseases; COVID-19; Humans; Hydroxychloroquine; Ivermectin; Pandemics; Ritonavir; SARS-CoV-2; United States | 2023 |
Repurposed drug studies on the primary prevention of SARS-CoV-2 infection during the pandemic: systematic review and meta-analysis.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; COVID-19; Humans; Hydroxychloroquine; Ivermectin; Pandemics; Primary Prevention; SARS-CoV-2 | 2023 |
4 trial(s) available for dextrothyroxine and hydroxychloroquine
| Article | Year |
|---|---|
The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Topics: Administration, Oral; Adult; Antiviral Agents; Clinical Trials, Phase III as Topic; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Intensive Care Units; Interferon beta-1a; Iran; Ivermectin; Length of Stay; Lopinavir; Male; Randomized Controlled Trials as Topic; Ritonavir; SARS-CoV-2; Severity of Illness Index | 2021 |
Phase 2 randomized study on chloroquine, hydroxychloroquine or ivermectin in hospitalized patients with severe manifestations of SARS-CoV-2 infection.
Topics: Adult; Aged; Antimalarials; Antiparasitic Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Female; Humans; Hydroxychloroquine; Inpatients; Ivermectin; Male; Middle Aged | 2021 |
Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
Topics: Aged; Amides; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; Azithromycin; COVID-19; COVID-19 Drug Treatment; Cytochrome P-450 CYP3A; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Ivermectin; Male; Middle Aged; Pneumonia, Viral; Prospective Studies; Pyrazines; Single-Blind Method; Treatment Outcome | 2021 |
Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial.
Topics: Antiparasitic Agents; COVID-19 Drug Treatment; Double-Blind Method; Humans; Hydroxychloroquine; Ivermectin; SARS-CoV-2; Time Factors; Treatment Outcome | 2022 |
19 other study(ies) available for dextrothyroxine and hydroxychloroquine
| Article | Year |
|---|---|
Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?
Topics: Betacoronavirus; Chemoprevention; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
COVID-19 and Fake News in the Dominican Republic.
Topics: Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Betacoronavirus; Civil Disorders; Coronavirus Infections; COVID-19; Dissent and Disputes; Dominican Republic; Drug Repositioning; Humans; Hydroxychloroquine; Ivermectin; Pandemics; Pneumonia, Viral; Politics; Public Health; SARS-CoV-2; Social Media; Trust | 2020 |
In Vitro Data of Current Therapies for SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Emetine; Homoharringtonine; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; SARS-CoV-2; Teicoplanin; Thiazoles | 2020 |
Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine.
Topics: Acute Generalized Exanthematous Pustulosis; Betacoronavirus; Chemoprevention; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Management of crash and burn patients with SARS-CoV-2 associated ARDS.
Topics: Adult Stem Cells; Angiotensin-Converting Enzyme 2; Azithromycin; Blood Component Transfusion; COVID-19; Extracorporeal Membrane Oxygenation; Humans; Hydroxychloroquine; Ivermectin; Plasma; Recombinant Proteins; Respiratory Distress Syndrome; SARS-CoV-2 | 2020 |
COVID-19: Panama stockpiles unproven drugs.
Topics: COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Ivermectin; Panama; Self Care; Social Isolation; Strategic Stockpile; Uncertainty | 2020 |
Multidrug treatment for COVID-19.
Topics: Azithromycin; COVID-19 Drug Treatment; Doxycycline; Drug Repositioning; Drug Therapy, Combination; Humans; Hydroxychloroquine; Ivermectin; Treatment Outcome | 2021 |
'I hope you die': how the COVID pandemic unleashed attacks on scientists.
Topics: Azithromycin; Bullying; Communication; COVID-19; Female; Health Policy; Humans; Hydroxychloroquine; Ivermectin; Male; Pandemics; Politics; Research Personnel; Violence | 2021 |
Ivermectin and Hydroxychloroquine for Chemo-Prophylaxis of COVID-19: A Questionnaire Survey of Perception and Prescribing Practice of Physicians vis-a-vis Outcomes.
Topics: COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Ivermectin; Pandemics; Perception; Physicians; SARS-CoV-2; Surveys and Questionnaires | 2021 |
Outcomes associated with Hydroxychloroquine and Ivermectin in hospitalized patients with COVID-19: a single-center experience.
Topics: COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Ivermectin; Retrospective Studies; SARS-CoV-2; Treatment Outcome | 2021 |
Rise of the preprint: how rapid data sharing during COVID-19 has changed science forever.
Topics: Antimalarials; Antiparasitic Agents; Communicable Disease Control; Contact Tracing; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Glucocorticoids; Humans; Hydroxychloroquine; Information Dissemination; Ivermectin; Meta-Analysis as Topic; Peer Review, Research; Preprints as Topic; Retraction of Publication as Topic; SARS-CoV-2; Scientific Misconduct | 2022 |
From hydroxychloroquine to ivermectin: how unproven "cures" can go viral.
Topics: COVID-19; Humans; Hydroxychloroquine; Ivermectin; SARS-CoV-2 | 2022 |
Association of County-Level Prescriptions for Hydroxychloroquine and Ivermectin With County-Level Political Voting Patterns in the 2020 US Presidential Election.
Topics: Humans; Hydroxychloroquine; Ivermectin; Politics; Prescriptions; United States | 2022 |
Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia.
Topics: Azithromycin; Calcitriol; Colchicine; COVID-19; COVID-19 Drug Treatment; Cross-Sectional Studies; Humans; Hydroxychloroquine; Ivermectin; Pandemics | 2022 |
Using Twitter data to understand public perceptions of approved versus off-label use for COVID-19-related medications.
Topics: COVID-19 Drug Treatment; Cytidine; Delivery of Health Care; Humans; Hydroxychloroquine; Hydroxylamines; Ivermectin; Off-Label Use; Pandemics; Public Opinion; Retrospective Studies; Social Media | 2022 |
Sales of "COVID kit" drugs and adverse drug reactions reported by the Brazilian Health Regulatory Agency.
Topics: Azithromycin; Brazil; Coronavirus Infections; COVID-19 Drug Treatment; Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Ivermectin; Pandemics; Pneumonia, Viral | 2022 |
Outpatient purchasing patterns of hydroxychloroquine and ivermectin in the USA and Canada during the COVID-19 pandemic: an interrupted time series analysis from 2016 to 2021.
Topics: COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Interrupted Time Series Analysis; Ivermectin; Outpatients; Pandemics; Retrospective Studies | 2022 |
The dangers of non-randomized, observational studies: experience from the COVID-19 epidemic.
Topics: COVID-19; Epidemics; Humans; Hydroxychloroquine; Ivermectin | 2023 |
Misinformation, Trust, and Use of Ivermectin and Hydroxychloroquine for COVID-19.
Topics: Adult; Communication; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Female; Humans; Hydroxychloroquine; Ivermectin; Male; Pandemics; Trust; United States | 2023 |